Medicines Patent Pool
banner
medicinespatentpool.org
Medicines Patent Pool
@medicinespatentpool.org
MPP aims to improve access to affordable #EssentialMedicines – including for treating #HIV #ViralHepatitis #TB #COVID-19 and #NCDs – in low- and middle-income countries through voluntary licensing and technology transfer.
medicinespatentpool.org
MPP’s work in #licensing, #techtransfer and capacity-building aligns with Article 12’s benefit-sharing goals. We’ve long partnered with @who.int and Member States to turn these principles into access. 🤝🌍

👉 medicinespatentpool.org/news-publica...
MPP's Statement at the WHO Intergovernmental Working Group - MPP
Question: “How could your entity contribute in a practical and sustainable manner to the Pathogen Access and Benefit Sharing System (PABS)?” Statement  We believe that Medicines Patent Pool (MPP) can ...
medicinespatentpool.org
November 24, 2025 at 2:43 PM
MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪

Would you like to explore ways in which we could collaborate? 🤝

Get in touch: medicinespatentpool.org/licensingsav...

#Sustainability #FundingHealthEquity
November 21, 2025 at 8:58 AM
Reposted by Medicines Patent Pool
One tablet could change everything.

The UNIVERSAL 1 trial is confirming the right dose for a single, dispersible DTG/FTC/TAF pill for children with #HIV, a formulation prioritised by GAP-f.

Watch for more

#BetterMeds4Kids #WorldChildrensDay #PaediatricHIV #EDCTP
World Children's Day 2025
YouTube video by Penta Child Health Research
youtu.be
November 20, 2025 at 12:49 PM
On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines.

Learn more: www.who.int/initiatives/...

@pablorojo.bsky.social @sebmoringva.bsky.social
November 20, 2025 at 1:20 PM
🦠 #RSV kills 100,000+ young children yearly, 97% in LMICs. Prevention works, but access to life-saving monoclonal antibodies is limited. On #WorldChildrensDay, let’s push for affordable RSV prevention so every child gets a healthy start. Learn more: bit.ly/4o0XGqo
Preventing a hidden killer of infants in low- and middle-income countries - MPP
Respiratory syncytial virus (RSV) is the leading causes of lower respiratory tract infections and mortality among young children across the world. Estimates suggest it causes over 100,000 deaths and 3...
bit.ly
November 20, 2025 at 8:41 AM
Reposted by Medicines Patent Pool
💊 Honored to welcome @medicinespatentpool.org to visit community-based organizations in Hanoi, with the connection from ViiV Healthcare.

Together, we shared how community-led HIV prevention and care are helping expand access to essential medicines and health services for all.
November 18, 2025 at 1:00 PM
Reposted by Medicines Patent Pool
Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍
November 20, 2025 at 8:22 AM
Our MPP team will be attending ICASA 2025 in Accra, Ghana 🇬🇭, just two weeks to go!

Feel free to reach out to connect and explore new collaboration opportunities.

Together, we can advance global health.🌍

#ICASA2025 #PublicHealth
@sebmoringva.bsky.social
November 19, 2025 at 2:57 PM
Reposted by Medicines Patent Pool
This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍
-
#BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 1:48 PM
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 9:15 AM
On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind.

🔗 bit.ly/3WYVNzB
November 14, 2025 at 3:14 PM
We're thrilled to welcome Mathieu Saint-Arnaud, Managing Director at Deutsche Bank, to the MPP's Governance Board! Mathieu’s expertise and global outlook will be invaluable as we advance MPP’s mission to improve access to #essential #medicines worldwide.

👉 medicinespatentpool.org/news-publica...
Mathieu Saint-Arnaud Joins MPP Governance Board - MPP
We are delighted to announce the appointment of Mathieu Saint-Arnaud as a new member of the MPP Governance Board. Mathieu currently serves as Managing Director at Deutsche Bank and brings nearly two d...
medicinespatentpool.org
November 14, 2025 at 11:38 AM
On #WorldPneumoniaDay, we spotlight #RSV — the leading cause of severe #pneumonia in infants. 100,000 child deaths yearly, 97% in LMICs. Prevention is critical, and access must improve.

Read how MPP is driving change: medicinespatentpool.org/story-post/p...
#BetterMeds4Kids
Preventing a hidden killer of infants in low- and middle-income countries - MPP
Respiratory syncytial virus (RSV) is the leading causes of lower respiratory tract infections and mortality among young children across the world. Estimates suggest it causes over 100,000 deaths and 3...
medicinespatentpool.org
November 13, 2025 at 8:19 AM
#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs.

Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...
November 13, 2025 at 8:18 AM
Reposted by Medicines Patent Pool
On #WorldPneumoniaDay, we share hope for the children battling severe pneumonia.

The PediCAP-A trial showed that it's safe to switch children from IV to oral antibiotics sooner!

✅ Children go home sooner
✅ No more unnecessary IVs & long stays

#PediCAP #ChildHealth #Pneumonia #GlobalHealth
November 12, 2025 at 8:20 AM
Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact.

Would you like to explore ways in which we could collaborate?
👉 medicinespatentpool.org/licensingsav...

#FundingHealthEquity #GlobalHealth
November 10, 2025 at 4:24 PM
With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth!

#Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs.

#AccessToMedicines #HealthEquity
November 7, 2025 at 4:42 PM
At 🇹🇳 #AORTIC2025, our #allwomen panel challenged one of the most persistent misconceptions in access to immuno-oncology in Africa.

✨ Thanks to all the speakers shaping this discussion!
November 4, 2025 at 9:21 AM
🌍 We’re hiring!

The Medicines Patent Pool is looking for:
- Programme Finance Officer
📅 Apply by: 31 October 2025
Learn more 👉 lnkd.in/eTYisnmb

- Consultant / Firm – LAMP Technology Assessment
🗓 Apply by: 3 November 2025
Learn more 👉 lnkd.in/ejkr4nTi
October 24, 2025 at 9:54 AM
🌏 Excited to share that Medicines Patent Pool was invited to the 5th Pharmaceutical Innovation Industry Conference 2025, in Shanghai!

#PharmaInnovation #GlobalHealth #AccessToMedicines
October 24, 2025 at 9:15 AM
🌍 MPP at #CPHIA2025

MPP is pleased to participate in this year’s #CPHIA2025, joining partners to discuss sustainable #localmanufacturing and equitable access to medical products across Africa.

@eburrone.bsky.social - @tiwabraimoh.bsky.social
October 20, 2025 at 8:20 AM
💊 The price of generic TLD (tenofovir, lamivudine, dolutegravir), the WHO-recommended HIV treatment, now costs under $37 per person per year, this has been a game changer in low- and middle-income countries.🌏

🤝 How we can collaborate together: medicinespatentpool.org/licensingsav...
October 15, 2025 at 11:54 AM
Meaningful days in Accra for #AHMTEC2025!

MPP’s Tiwadayo Braimoh and Meghmala Das joined a panel on #licensing opportunities for African manufacturing, showcasing how the MPP model supports access to essential health products and builds sustainable manufacturing capacity across #Africa.
October 13, 2025 at 11:25 AM
🌍 We’re hiring!

The Medicines Patent Pool is looking for a Programme Finance Officer to join our team in Geneva, Switzerland.

📅 Apply by: 31 October 2025
📧 Send your application to: recruitment@medicinespatentpool.org

Learn more 👉 medicinespatentpool.org/call-for-app...
October 9, 2025 at 12:35 PM
MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs.

👉 medicinespatentpool.org/story-post/m...
October 6, 2025 at 9:37 AM